Skip to main content
PMC home page
Infection and Immunity logoLink to Infection and Immunity
. 1980 Jun;28(3):837–841. doi: 10.1128/iai.28.3.837-841.1980

Bactericidal activity of human serum against Escherichia coli chi1776.

W J Alexander, L S Alexander, R Curtiss 3rd
PMCID: PMC551026  PMID: 6995323

Abstract

Escherichia coli chi1776 is a host strain providing the EK2 level of biological containment. Laboratories equipped to use this strain may be located near medical care facilities where patients prone to infection may be found. We have therefore documented the marked susceptibility of chi1776 to killing by human serum from normal as well as ill individuals.

Full text

PDF
837

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Agnello V. Complement deficiency states. Medicine (Baltimore) 1978 Jan;57(1):1–23. doi: 10.1097/00005792-197801000-00001. [DOI] [PubMed] [Google Scholar]
  2. Akiyama Y., Inoue K. Isolation and properties of complement-resistant strains of Escherichia coli K-12. Infect Immun. 1977 Nov;18(2):446–453. doi: 10.1128/iai.18.2.446-453.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Durack D. T., Beeson P. B. Protective role of complement in experimental Escherichia coli endocarditis. Infect Immun. 1977 Apr;16(1):213–217. doi: 10.1128/iai.16.1.213-217.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Elgefors B., Olling S. The significance of serum-sensitive bacilli in gram-negative bacteremia. Scand J Infect Dis. 1978;10(3):203–207. doi: 10.3109/inf.1978.10.issue-3.08. [DOI] [PubMed] [Google Scholar]
  5. Feingold D. S. The serum bactericidal reaction. IV. Phenotypic conversion of Escherichia coli from serum-resistance to serum-sensitivity by diphenylamine. J Infect Dis. 1969 Oct;120(4):437–444. doi: 10.1093/infdis/120.4.437. [DOI] [PubMed] [Google Scholar]
  6. Fietta A., Romero E., Siccardi A. G. Effect of some R factors on the sensitivity of rough Enterobacteriaceae to human serum. Infect Immun. 1977 Nov;18(2):278–282. doi: 10.1128/iai.18.2.278-282.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Howard C. J., Glynn A. A. The virulence for mice of strains of Escherichia coli related to the effects of K antigens on their resistance to phagocytosis and killing by complement. Immunology. 1971 May;20(5):767–777. [PMC free article] [PubMed] [Google Scholar]
  8. Johnston R. B., Jr, Stroud R. M. Complement and host defense against infection. J Pediatr. 1977 Feb;90(2):169–179. doi: 10.1016/s0022-3476(77)80625-2. [DOI] [PubMed] [Google Scholar]
  9. KENT J. F., FIFE E. H., Jr Precise standardization of reagents for complement fixation. Am J Trop Med Hyg. 1963 Jan;12:103–116. doi: 10.4269/ajtmh.1963.12.103. [DOI] [PubMed] [Google Scholar]
  10. LENNOX E. S. Transduction of linked genetic characters of the host by bacteriophage P1. Virology. 1955 Jul;1(2):190–206. doi: 10.1016/0042-6822(55)90016-7. [DOI] [PubMed] [Google Scholar]
  11. McCabe W. R., Kaijser B., Olling S., Uwaydah M., Hanson L. A. Escherichia coli in bacteremia: K and O antigens and serum sensitivity of strains from adults and neonates. J Infect Dis. 1978 Jul;138(1):33–41. doi: 10.1093/infdis/138.1.33. [DOI] [PubMed] [Google Scholar]
  12. Medearis D. N., Jr, Kenny J. F. Observations concerning the pathogenesis of E. coli infections in mice. J Immunol. 1968 Sep;101(3):534–540. [PubMed] [Google Scholar]
  13. Newman S. L., Vogler L. B., Feigin R. D., Johnston R. B., Jr Recurrent septicemia associated with congenital deficiency of C2 and partial deficiency of factor B and the alternative complement pathway. N Engl J Med. 1978 Aug 10;299(6):290–292. doi: 10.1056/NEJM197808102990606. [DOI] [PubMed] [Google Scholar]
  14. Olling S., Hanson L. A., Holmgren J., Jodal U., Lincoln K., Lindberg U. The bactericidal effect of normal human serum on E. coli strains from normals and from patients with urinary tract infections. Infection. 1973;1(1):24–28. doi: 10.1007/BF01638251. [DOI] [PubMed] [Google Scholar]
  15. Orskov I., Orskov F., Jann B., Jann K. Serology, chemistry, and genetics of O and K antigens of Escherichia coli. Bacteriol Rev. 1977 Sep;41(3):667–710. doi: 10.1128/br.41.3.667-710.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Petersen B. H., Lee T. J., Snyderman R., Brooks G. F. Neisseria meningitidis and Neisseria gonorrhoeae bacteremia associated with C6, C7, or C8 deficiency. Ann Intern Med. 1979 Jun;90(6):917–920. doi: 10.7326/0003-4819-90-6-917. [DOI] [PubMed] [Google Scholar]
  17. Pruzanski W., Leers W. D., Wardlaw A. C. Bactericidal and bacteriolytic activity of leukemic sera. Cancer Res. 1973 Sep;33(9):2048–2053. [PubMed] [Google Scholar]
  18. ROWLEY D. The virulence of strains of Bacterium coli for mice. Br J Exp Pathol. 1954 Dec;35(6):528–538. [PMC free article] [PubMed] [Google Scholar]
  19. Reed W. P., Albright E. L. Serum factors responsible for killing of Shigella. Immunology. 1974 Jan;26(1):205–215. [PMC free article] [PubMed] [Google Scholar]
  20. Reynard A. M., Beck M. E. Plasmid-mediated resistance to the bactericidal effects of normal rabbit serum. Infect Immun. 1976 Sep;14(3):848–850. doi: 10.1128/iai.14.3.848-850.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Roantree R. J., Rantz L. A. A STUDY OF THE RELATIONSHIP OF THE NORMAL BACTERICIDAL ACTIVITY OF HUMAN SERUM TO BACTERIAL INFECTION. J Clin Invest. 1960 Jan;39(1):72–81. doi: 10.1172/JCI104029. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Ruddy S., Gigli I., Austen K. F. The complement system of man. I. N Engl J Med. 1972 Sep 7;287(10):489–495. doi: 10.1056/NEJM197209072871005. [DOI] [PubMed] [Google Scholar]
  23. Schmidt G. Genetical studies on the lipopolysaccharide structure of Escherichia coli K12. J Gen Microbiol. 1973 Jul;77(1):151–160. doi: 10.1099/00221287-77-1-151. [DOI] [PubMed] [Google Scholar]
  24. Taylor P. W. Genetical studies of serum resistance in Escherichia coli. J Gen Microbiol. 1975 Jul;89(1):57–66. doi: 10.1099/00221287-89-1-57. [DOI] [PubMed] [Google Scholar]
  25. Taylor P. W., Hughes C. Plasmid carriage and the serum sensitivity of enterobacteria. Infect Immun. 1978 Oct;22(1):10–17. doi: 10.1128/iai.22.1.10-17.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Traub W. H., Kleber I. Selective activation of classical and alternative pathways of human complement by "promptly serum-sensitive" and "delayed serum-sensitive" strains of Serratia marcescens. Infect Immun. 1976 May;13(5):1343–1346. doi: 10.1128/iai.13.5.1343-1346.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Vogler L. B., Newman S. L., Stroud R. M., Johnston R. B., Jr Recurrent meningococcal meningitis with absence of the sixth component of complement: an evaluation of underlying immunologic mechanisms. Pediatrics. 1979 Oct;64(4):465–467. [PubMed] [Google Scholar]
  28. WARDLAW A. C. The complement-dependent bacteriolytic activity of normal human serum. I. The effect of pH and ionic strength and the role of lysozyme. J Exp Med. 1962 Jun 1;115:1231–1249. doi: 10.1084/jem.115.6.1231. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES